RCC2 and glioblastoma: Besides, RCC2 expression was significantly negatively associated with the immune score in 13 tumors, including GBM, CESC, LUAD, ESCA, STES, STAD, UCEC, LUSC, SKCM-M, SKCM, OV, SKCM-P, and BLCA.